Obstetrics & Gynecology Doctors in Yankton, SD Accepting Medicare

6 Obstetrics & Gynecology doctors found. Showing 1 - 6

Spencer R Ferrell, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1104 W 8th St, Yankton, SD 57078 Phone: 605-665-7841    Fax: 605-665-0546

Dr. Emma M Bye, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1104 W 8th St, Yankton, SD 57078 Phone: 605-665-7841    Fax: 605-665-0546

Amy M Eichfeld, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1104 W 8th St, Yankton, SD 57078 Phone: 605-665-7841    Fax: 605-665-0546

Robert T Ferrell, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1104 W 8th St, Yankton, SD 57078 Phone: 605-665-7841    Fax: 605-665-0546

Dr. Jill F Sternquist, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1104 W 8th St, Yankton, SD 57078 Phone: 605-665-7841    Fax: 605-665-0546

Kevin B Bray, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1104 W 8th St, Yankton, SD 57078 Phone: 605-665-7841    Fax: 605-665-0546

News Archive

Why employers may eye health law exchange plans

Premiums for plans sold through the online marketplaces are lower, across the board, than the average premiums for the majority of Americans with work-based coverage, according to a report by PwC's Health Research Institute. Meanwhile, California lawmakers criticize the hiring of people with criminal records to be insurance counselors and labor leaders continue to complain the law will undermine coverage for their members.

Doctor speaks on health effects of chronic inflammation

If your body is in a chronic state of inflammation, it can have serious effects on your cellular health, and has been linked to degenerative diseases including cancer, heart disease, diabetes, Alzheimer's and many others. Luckily, there are numerous ways to control chronic inflammation naturally and promote overall health in the process.

Merck returns worldwide development and commercialization rights for AN2690 to Anacor Pharmaceuticals

Anacor Pharmaceuticals announced today that Merck has returned full worldwide development and commercialization rights for AN2690 to Anacor. AN2690 is a topical anti-fungal therapy being developed for onychomycosis, a fungal infection of the nail and nail bed. It is estimated that onychomycosis affects approximately 35 million people in the United States.

Study reveals link between childhood abuse and higher arthritis risk in adulthood

In a survey-based study of 21,889 adults in Canada, severe and/or frequent physical abuse during childhood and frequent childhood exposure to intimate partner violence were linked with higher risks or arthritis during adulthood arthritis, even after controlling for a range of factors. The findings are published in Arthritis Care & Research.

Read more Medical News

› Verified 1 days ago